Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase”

키워드

참고문헌 (15)

1. Jeong-Ju Yoo, "Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase", Clinical and Molecular Hepatology, 29(2), pp.482~495 (2023), 대한간학회
2. Feld JJ, "Characteristics of older patients with immunotolerant chronic hepatitis B virus infection", Clin Gastroenterol Hepatol (2022)[DOI]
3. Hui CK, "Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase", Hepatology, 46, pp.395~401 (2007)
4. Seto WK, "A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B", PLoS One, 7, pp.e32622~ (2012)
5. Andreani T, "Chronic hepatitis B virus carriers in the immunotolerant phase of infection : histologic findings and outcome", Clin Gastroenterol Hepatol, 5, pp.636~641 (2007)
6. Chu CM, "Correlation of age with the status of hepatitis B virus replication and histological changes in chronic type B hepatitis", Liver, 5, pp.117~122 (1985)
7. Chu CM, "Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels", Am J Med, 116, pp.829~834 (2004)
8. Chu CM, "Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B : a longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline", J Hepatol, 43, pp.411~417 (2005)
9. Terrault NA, "Update on prevention, diagnosis, and treatment of chronic hepatitis B : AASLD 2018 hepatitis B guidance", Hepatology, 67, pp.1560~1599 (2018)
10. European Association for the Study of the Liver, "EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection", J Hepatol, 67, pp.370~398 (2017)
11. He D, "Liver histology according to differing alanine aminotransferase level in immune tolerance phase patients with chronic hepatitis B virus infection", J Liver Clin Res, 2, pp.1007~ (2015)[DOI]
12. Chu CM, "Management of older Patients with Immunotolerant Chronic Hepatitis B Infection", Clin Gastroenterol Hepatol (2022)[DOI]
13. Lee HA, "Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase", Aliment Pharmacol Ther, 52, pp.196~204 (2020)
14. Lee HW, "Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis B", Eur J Intern Med, 84, pp.68~73 (2021)
15. Mi Young Jeon, "Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B", Clinical and Molecular Hepatology, 27(2), pp.295~304 (2021), 대한간학회[DOI]

관련 논문AI추천